The October issue of the OIF E-Newsletter is here! Read about Updates from the OIF, OI Research, Upcoming Events, and more at https://mailchi.mp/oif/october2024
Month: October 2024
Ultragenyx Receives Breakthrough Therapy Designation for Setrusumab (UX143) in OI
The OI Foundation would like to bring your attention to an update from Ultragenyx!
Ultragenyx Receives Breakthrough Therapy Designation for Setrusumab (UX143) in Osteogenesis Imperfecta
